Drug delivery systems based on mesoporous silica nanoparticles for the management of hepatic diseases
aSchool of Pharmacy, China Medical University, Shenyang 110122, China
bChina Medical University and Queen University of Belfast Joint College, China Medical University, Shenyang 110122, China
cDepartment of Organ Transplantation and Hepatobiliary, the First Hospital of China Medical University, Shenyang 110001, China
dDepartment of Pharmacy, the First Hospital of China Medical University, Shenyang 110001, China
* Corresponding authors.
收起